James Schoonover

Track

Insider profile

Currently holds positions in Abundia Global Impact Group, Inc and MEDTOX Scientific Inc

Performance

Overall performance
2.4
Performance over holding periods
2.4
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 31% 68% 82%
Transactions
3 67% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Interim Chief Executive Officer, Director Abundia Global Impact Group, Inc June 5, 2018 -
Vice President - Sales and Marketing and Chief Marketing Officer MEDTOX Scientific Inc July 17, 2000 -
Director Abundia Global Impact Group, Inc April 13, 2018 - June 5, 2018
James Schoonover's trades of Abundia Global Impact Group, Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-05-18 2023-05-18
B Purchase
61,941 +34.2%
460.81
US$1,456,006 		61,941 +34.2% 460.81 US$1,456,006
2022-09-02 2022-09-02
B Purchase
44,452 -34.1%
341.14
US$487,459 		44,452 -34.1% 341.14 US$487,459
2021-01-28 2021-01-26
S Sale
30,442 -37.8%
463.78
US$1,786,034 		30,442 -37.8% 463.78 US$1,786,034